Ironwood Pharmaceuticals Inc (IRWD) — Capital Reinvestment Ratio
Ironwood Pharmaceuticals Inc (IRWD) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow ($74.58 Million) in capital expenditures ($1.00K). Check IRWD goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Ironwood Pharmaceuticals Inc Capital Reinvestment Ratio (2019–2025)
This chart tracks Ironwood Pharmaceuticals Inc's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see Ironwood Pharmaceuticals Inc cash flow conversion.
Annual Capital Reinvestment Ratio for Ironwood Pharmaceuticals Inc (2019–2025)
Year-by-year Capital Reinvestment Ratio for Ironwood Pharmaceuticals Inc from 2019 to 2025. See IRWD cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | $127.04 Million | $34.00K | ▼ -80.5% |
| 2024 | 0.00x | $103.55 Million | $142.00K | ▼ -7.9% |
| 2023 | 0.00x | $183.43 Million | $273.00K | ▲ +199.6% |
| 2022 | 0.00x | $273.76 Million | $136.00K | ▼ -50.9% |
| 2021 | 0.00x | $261.89 Million | $265.00K | ▼ -90.7% |
| 2020 | 0.01x | $168.84 Million | $1.84 Million | ▼ -98.4% |
| 2019 | 0.67x | $10.72 Million | $7.19 Million | — |